Virus like particles as a platform for cancer vaccine development

QR Code

Virus like particles as a platform for cancer vaccine development

Cancers have killed millions of people in human history and are still posing a serious health problem worldwide. Therefore, there is an urgent need for developing preventive and therapeutic cancer vaccines. Among various cancer vaccine development platforms, virus-like particles (VLPs) offer several...

Full description

Bibliographic Details
Main Authors:	Hui, Kian Ong, Wen, Siang Tan, Kok, Lian Ho
Format:	Article
Language:	English
Published:	PeerJ 2017
Online Access:	http://psasir.upm.edu.my/id/eprint/63688/ http://psasir.upm.edu.my/id/eprint/63688/1/Virus%20like%20particles%20as%20a%20platform%20for.pdf

Similar Items

Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
by: Ong, Hui Kian
Published: (2018)

Virus-like particle vaccines: a prospective panacea against an avian influenza panzootic
by: Ninyio, Nathaniel Nyakaat, et al.
Published: (2020)

Virus-like particles of nodavirus displaying the receptor binding domain of SARS-CoV-2 spike protein: a potential VLP-based COVID-19 vaccine
by: Kumar, Kiven, et al.
Published: (2023)

Chimeric virus-like particles of prawn nodavirus displaying hepatitis B virus immunodominant region: biophysical properties and cytokine response
by: Ninyio, Nathaniel Nyakaat, et al.
Published: (2021)

Production of the virus-like particles of nipah virus matrix protein in Pichia pastoris as diagnostic reagents
by: Joseph, Narcisse M. S., et al.
Published: (2016)

Immunological analysis of the Hepatitis B virus “a” determinant displayed on chimeric virus-like particles of Macrobrachium rosenbergii nodavirus capsid protein produced in Sf9 cells
by: Ninyio, Nathaniel Nyakaat, et al.
Published: (2020)

Infectious hematopoietic necrosis virus: advances in diagnosis and vaccine development
by: Chean, Yeah Yong, et al.
Published: (2019)

Virus-like particles of Macrobrachium rosenbergii nodavirus: particle size and capsid protein assembly domain
by: Ganesan, Hagilaa, et al.
Published: (2022)

Virus-like particles of macrobrachium rosenbergii nodavirus capsid as a carrier for immunogenic components
by: Tan, Wen Siang, et al.
Published: (2014)

Virus-like particles of Macrobrachium rosenbergii nodavirus produced in bacteria
by: Zee, Hong Goh, et al.
Published: (2011)

Hepatitis B virus-like particle: targeted delivery of plasmid expressing short hairpin RNA for silencing the Bcl-2 gene in cervical cancer cells
by: Akwiditya, Made Angga, et al.
Published: (2021)

Broadly cross-reactive immune responses in chickens immunized with chimeric virus-like particles of nodavirus displaying the M2e originated from avian and human influenza A viruses
by: Thian, Bernard Yi Zhe, et al.
Published: (2025)

Targeted delivery of cell penetrating peptide virus-like nanoparticles to skin cancer cells
by: Gan, Bee Koon, et al.
Published: (2018)

Immunogenicity of Matrix protein 2 ectodomain (M2e) displayed on Nodavirus-like particles as Avian influenza vaccine for poultry
by: Mohamad Abir, Anis Suraya, et al.
Published: (2025)

Recent advances in the vaccine development against Middle East respiratory syndrome- coronavirus
by: Yong, Chean Yeah, et al.
Published: (2019)

A simple add-and display method for immobilisation of cancer drug on his-tagged virus-like nanoparticles for controlled drug delivery
by: Biabanikhankahdani, Roya, et al.
Published: (2017)

Production of the matrix protein of nipah virus in escherichia coli: virus-like particles and possible application in diagnosis.
by: Senthil, Kumar Subramanian, et al.
Published: (2009)

Tracking the virus-like particles of Macrobrachium rosenbergii nodavirus in insect cells
by: Hanapi, Ummi Fairuz, et al.
Published: (2017)

Development of Macrobrachium rosenbergii nodavirus virus-like particles-based Japanese encephalitis virus and severe acute respiratory syndrome coronavirus-2 vaccines
by: Karunanithi, Kiven Kumar
Published: (2022)

Immunological analysis of Nodavirus capsid displaying the domain III of Japanese Encephalitis Virus evelope protein
by: Kumar, Kiven, et al.
Published: (2021)

Phage display creates innovative applications to combat hepatitis B virus
by: Tan, Wen Siang, et al.
Published: (2014)

An N-terminal extension to the hepatitis B virus core protein forms a poorly ordered trimeric spike in assembled virus-like particles
by: McGonigle, Richard, et al.
Published: (2015)

Negative chromatography of hepatitis B virus-like particles: comparative study of different adsorbent designs
by: Lee, Micky Fu Xiang, et al.
Published: (2016)

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
by: Yong, Chean Yeah, et al.
Published: (2015)

Virus-like particles of Macrobrachium rosenbergii de man nodavirus for discovery of anti-virus peptides and delivery of a cancer drug
by: Thong, Qiu Xian
Published: (2019)

Shielding of hepatitis B virus-like nanoparticle with poly(2-ethyl-2-oxazoline)
by: Fam, See Yee, et al.
Published: (2019)

Virus-like particle of Macrobrachium rosenbergii nodavirus produced in Spodoptera frugiperda (Sf9) cells is distinctive from that produced in Escherichia coli
by: Kueh, Chare Li, et al.
Published: (2017)

Construction and characterization of avian papillomavirus L1 virus-like particles
by: Abdul Latif, Nur 'Atikah
Published: (2021)

Peptides that inhibit the association of the surface and core antigens of hepatitis B virus
by: Tan, Wen Siang, et al.
Published: (2001)

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein.
by: Lee, Khai Wooi, et al.
Published: (2008)

Delivery of chimeric hepatitis B core particles into liver cells.
by: Tan, Wen Siang, et al.
Published: (2012)

An influenza A vaccine based on the extracellular domain of matrix 2 protein protects BALB/C mice against H1N1 and H3N2
by: Ong, Hui Kian, et al.
Published: (2019)

Oligomerization state of the multimerization domain of Nipah virus phosphoprotein
by: Salvamani, Shamala, et al.
Published: (2013)

Size-selective purification of hepatitis B virus-like particle in flow-through chromatography: Types of ion exchange adsorbent and grafted polymer architecture
by: Ng, Hon Wei, et al.
Published: (2018)

Size‐selective purification of hepatitis B virus‐like particle in flow‐through chromatography: types of ion exchange adsorbent and grafted polymer architecture
by: Ng, Hon Wei, et al.
Published: (2018)

Size-selective purification of hepatitis B virus-like particle in flow-through chromatography: types of ion exchange adsorbent and grafted polymer architecture
by: Hon, Wei Ng, et al.
Published: (2018)

Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
by: Biabanikhankahdani, Roya
Published: (2017)

Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM)
by: Yusoff, Khatijah, et al.
Published: (1996)

Targeted delivery of short hairpin RNA expressing plasmid using hepatitis B virus-like particle for bcl-2 gene silencing in cervical cancer cells
by: Akwiditya, Made Angga
Published: (2021)

Toll-like receptor 7 and 8 polymorphisms: Associations with functional effects and cellular and antibody responses to measles virus and vaccine
by: Clifford, H., et al.
Published: (2012)